Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
TRACER logo — Accelerating your clinical trial by generating early accurat...

TRACER

Accelerating your clinical trial by generating early accurate in-human data on your drug | Molecular imaging

Founded 2017 The Netherlands The Netherlands 79 employees Biotechnology

General Information

Company Name TRACER
Founded Year 2017
Location The Netherlands The Netherlands
Founders / Decision Makers
Team member
Employees 79
Industries Biotechnology
Social

BounceWatch is an independent company data service, not affiliated with TRACER. To contact TRACER, visit tracercro.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does TRACER compare?

A PDF of TRACER and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting TRACER soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About TRACER

TRACER is a biotechnology startup founded in 2017 with a focus on accelerating clinical trials through early and accurate in-human data generation for drugs using molecular imaging techniques. The company specializes in first-in-human studies, leveraging nuclear and optical molecular imaging to label various compounds for fast data acquisition on potential drug efficacy, even preceding the traditional phase 1-3 clinical trials. This approach ultimately aims to streamline and reduce the cost of the drug development process. TRACER collaborates with sponsors to label lead compounds and conduct first-in-human studies to visualize and quantify biodistribution and pharmacokinetics, enabling informed "go/no-go" decisions before progressing to the next phase of clinical development. Notably, early in-human studies are EMA and FDA-approved through the principle of microdosing, potentially bypassing extensive animal models. Currently, there is no publicly available information on the last investment or the investors involved in TRACER.

Business keywords: Molecular imaging, Nuclear imaging, Optical imaging, Drug development, Clinical trials, Microdosing, In-human data, Proof of Concept (PoC) study, Pharmacokinetics, Fluorescent imaging, Tracers, Oncology, Infectious diseases, Cardiovascular diseases, Inflammatory diseases

No funding data available for TRACER yet.

TRACER Alternatives & Competitors

View All Alternatives
TRACER vs
Fractal Therapeutics
Fractal Therapeutics United States

Model-based drug discovery & development services, helping clients get candidate drug molecules to m...

6 employees
Biotechnology, Health and Wellness
TRACER vs
MITRO (Nanjing) Biotech Co., Ltd.
MITRO (Nanjing) Biotech Co., Ltd. China

米度（南京）生物技术有限公司是国内首家分子影像医药研发外包（MI-CRO）企业。公司利用世界先进的放射标记...

Venture round
5 employees
Biopharma, Biotechnology
TRACER vs
G2M | Next Generation IVD solutions for Genomics
G2M | Next Generation IVD solutions for Genomics India

Revolutionizing Molecular Diagnostics with world-class Innovative IVD Solutions.

103 employees
Biotechnology, Health Care
View all alternatives

FAQ About TRACER

Accelerating your clinical trial by generating early accurate in-human data on your drug | Molecular imaging
TRACER was founded in 2017.
TRACER is headquartered in The Netherlands.
TRACER operates in Biotechnology. Its work centres on Molecular imaging, Nuclear imaging, Optical imaging and Drug development.
TRACER has approximately 79 employees.
Top alternatives and competitors to TRACER include Fractal Therapeutics, MITRO (Nanjing) Biotech Co., Ltd., G2M | Next Generation IVD solutions for Genomics, Crux Biolabs, Flame Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
TRACER and Fractal Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for TRACER, https://bouncewatch.com/company/tracer-2, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes